Reuters.comJ&J pulls COVID vaccine sales forecast due to low demand, supply glutApr 19, 2022Michael Erman & Manas MishraBy Michael Erman & Manas Mishramore_vert
FiercePharmaJohnson & Johnson drops COVID-19 vaccine projections, reduces 2022 revenue forecastApr 19, 2022Kevin DunleavyBy Kevin Dunleavymore_vert